APA (7th ed.) Citation

HC, G., E, W., B, C., R, D., K, D., S, H., . . . MA, P. (2023). Effect of lixisenatide on natriuretic peptides in people with type 2 diabetes and recent acute coronary syndrome: The ELIXA trial. Diabetes, obesity & metabolism, 25(4), 1125. https://doi.org/10.1111/dom.14954

Chicago Style (17th ed.) Citation

HC, Gerstein, et al. "Effect of Lixisenatide on Natriuretic Peptides in People with Type 2 Diabetes and Recent Acute Coronary Syndrome: The ELIXA Trial." Diabetes, Obesity & Metabolism 25, no. 4 (2023): 1125. https://doi.org/10.1111/dom.14954.

MLA (9th ed.) Citation

HC, Gerstein, et al. "Effect of Lixisenatide on Natriuretic Peptides in People with Type 2 Diabetes and Recent Acute Coronary Syndrome: The ELIXA Trial." Diabetes, Obesity & Metabolism, vol. 25, no. 4, 2023, p. 1125, https://doi.org/10.1111/dom.14954.